CAR T cells and T cell engagers for autoimmunity—lessons from hematology

• by Sarah Kayser, Arnon Nagler

• February 23, 2026

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

A new era in transplantation is here. Roswell Park reports a remarkable 92.6% one-year survival rate following allogeneic transplant—well above the national average—thanks to evidence-based innovations transforming patient care.

• July 8, 2026

• 4 min

Peripheral blood DNA methylation changes precede lymphoma diagnosis in primary Sjögren's disease

• by Hanna Lidberg, Cecilia Fugmann, Juliana Imgenberg-Kreuz

• July 9, 2026

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma

• by Leo Rasche, Maria Theresa Krauth, Hermine Agis, Christoph Renner, Irene Strassl, Raphael Teipel, Vladan Vučinić, Katja Weisel, Wolfgang Willenbacher, Marc S. Raab

• May 13, 2026